| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
D Matthew Dorny last filed a Form 4 in July 2021, as General Counsel at NUS. From February 2015 to July 2021, the filings on record show 0 open-market purchases and 31 sales. D Matthew Dorny's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, D Matthew Dorny's trades have earned a middling insider score of 66/100 across 4 rated trades. Over a 12-month horizon, all 4 of those trades were profitable, with an average 12-month return of +17.5%.
At the last filing, the largest reported position was 47,159 shares of NUS. The NUS filings lean toward selling, a net 212,500 shares.
Shares as reported in the last Form 4 for each company; the most recent is from July 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2016 | NUS Nu Skin Enterprises, Inc. | General Counsel | Sell | 20,000 | $54.33 | $1,086,600.00 | -31.6% |